AP
About
Apollomics is an innovative biopharmaceutical company committed to the discovery and development of mono- and combination-oncology therapies to harness the immune system and target specific molecular pathways to eradicate cancer. The company’s existing pipeline consists of several development-stage assets, including the novel, humanized monoclonal antibodies that restore the body’s immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 22 investors are based in Foster City, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Foster City, US
Contact Information
Find more investors like Apollomics
Search Investors